News Archive

Walbrook PR AIM IPO - Intuitive Investments Group plc

14 December 2020

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to the recent AIM IPO of Intuitive Investments Group plc, the closed-end investment company focused on the life sciences sector. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

Intuitive Investments Group plc (AIM: IIG) is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US. Utilising the Board's experience and in particular that of the Chairman, David Evans, who has over 27 years of experience in the Life Science sector, the Company seeks to generate capital growth over the long term for shareholders.

The Company invests in four main areas across the life sciences spectrum:

  • Tools and Technologies
  • Diagnostics and Healthcare
  • Medical Devices
  • Biotherapeutics and Pharmaceuticals

Recent investments include the £1 million investment in Light Science Technologies Limited, a UK-based lighting technology company, another £1 million investment in BioQ Pharma Incorporated, a commercial-stage medical device and pharmaceutical company, and a £250,000 investment in Microsaic Systems plc, a high technology company which develops point-of-need mass spectrometers.

For more information visit the Company’s website:

Paul McManus, Founder and Managing Director of Walbrook PR, commented: “We are proud to have supported the Intuitive team with its IPO. The Company has excellent potential, boasting an experienced investment team and advisory panel, led by David Evans and Dr Stuart White respectively. The Company has developed an exciting and extensive pipeline of investments in the life sciences space to pursue in the near future, and we look forward to working with the Company as they continue to expand their portfolio.”


For further information please contact:

Paul McManus Tel: 020 7933 8787 Mob: 07980 541 893 [email protected]


About Walbrook PR:                                                                                    

Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM listed companies.

Walbrook PR is ranked 2nd in the AIM Adviser Rankings guide and is ranked 7th by total number of Stock Market listed clients. Walbrook acts for 56 listed companies (mainly AIM) across a wide mix of sectors and is ranked 1st in Healthcare and 4th in Technology, by number of AIM clients.

Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM listed companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business. 

Who We Work With